Journal articles
O’Neill D; Hodgkinson S, 2020, 'Short term efficacy and safety outcomes after switching from Anti-CD20 DMTs to Cladribine in a real-world setting (5389)', Neurology, 94, http://dx.doi.org/10.1212/wnl.94.15_supplement.5389
Fambiatos A; Jokubaitis V; Horakova D; Kubala Havrdova E; Trojano M; Prat A; Girard M; Duquette P; Lugaresi A; Izquierdo G; Grand’Maison F; Grammond P; Sola P; Ferraro D; Alroughani R; Terzi M; Hupperts R; Boz C; Lechner-Scott J; Pucci E; Bergamaschi R; Van Pesch V; Ozakbas S; Granella F; Turkoglu R; Iuliano G; Spitaleri D; McCombe P; Solaro C; Slee M; Ampapa R; Soysal A; Petersen T; Sanchez-Menoyo JL; Verheul F; Prevost J; Sidhom Y; Van Wijmeersch B; Vucic S; Cristiano E; Saladino ML; Deri N; Barnett M; Olascoaga J; Moore F; Skibina O; Gray O; Fragoso Y; Yamout B; Shaw C; Singhal B; Shuey N; Hodgkinson S; Altintas A; Al-Harbi T; Csepany T; Taylor B; Hughes J; Jun JK; van der Walt A; Spelman T; Butzkueven H; Kalincik T, 2020, 'Risk of secondary progressive multiple sclerosis: A longitudinal study', Multiple Sclerosis Journal, 26, pp. 79 - 90, http://dx.doi.org/10.1177/1352458519868990
Lau FS; Mitchelle A; Cheung A; Wenderoth J; Cappelen-Smith C; Cordato D; Hodgkinson S; McDougall A; Zagami AS; Manning NW, 2020, 'Abstract TMP9: Use of Immediate Dual Antiplatelet Therapy in Carotid Stenting for Tandem Occlusion Stroke is Associated With Acceptable Symptomatic Intracranial Haemorrhage Rates', Stroke, 51, http://dx.doi.org/10.1161/str.51.suppl_1.tmp9
McQuinn A; Cheung A; Wenderoth J; Mitchelle A; Blair C; Cappelen-Smith C; Cordato D; Hodgkinson S; McDougall A; Zagami AS; Manning NW, 2020, 'Abstract TP32: Efficacy and Safety of Hyper-acute Stenting for Symptomatic Intracranial Atherosclerotic Disease', Stroke, 51, http://dx.doi.org/10.1161/str.51.suppl_1.tp32
Mitchelle A; Lau FS; Cheung A; Wenderoth J; McQuinn A; Cappelen-Smith C; Cordato D; Hodgkinson S; Blair C; McDougall A; Zagami AS; Manning NW, 2020, 'Abstract WP57: Acute Carotid Stenting Following Intracranial Thrombectomy Has Comparable Safety and Efficacy in Early versus Late Time Window Stroke', Stroke, 51, http://dx.doi.org/10.1161/str.51.suppl_1.wp57
Verma ND; Al-Atiyah R; Tran GT; Hodgkinson SJ; Hall BM, 2020, 'CHANGES IN PHENOTYPE OF HUMAN CD4+CD25+CD127LO TREG SUBPOPULATIONS AFTER CULTURE WITH RIL-2 AND ALLOANTIGEN', Transplantation, 104, pp. S162 - S162, http://dx.doi.org/10.1097/01.tp.0000699152.96447.5a
Rakesh P; Verma ND; Bedi SK; Tran GT; Robinson CM; Hodgkinson SJ; Hall BM, 2020, 'COMPARISON OF TRITIATED THYMIDINE INCORPORATION ASSAY AND AN IN VITRO SUPPRESSION ASSAY OF CD4+CD25-T EFFECTOR CELL PROLIFERATION BY TH2-LIKE TREG AND NAÏVE TREG USING A FLOW CYTOMETRY BASED ASSAY', Transplantation, 104, pp. S162 - S162, http://dx.doi.org/10.1097/01.tp.0000699156.74079.68
Ledingham D; El-Wahsh S; Sebire D; Cappelen-Smith C; Hodgkinson SJ; McDougall AJ; Maley M; Cordato DJ, 2019, 'Adjuvant immunosuppression for paradoxical deterioration in tuberculous meningitis including one case responsive to cyclosporine. A tertiary referral hospital experience', Journal of the Neurological Sciences, 404, pp. 58 - 62, http://dx.doi.org/10.1016/j.jns.2019.07.002
Hall BM; Tran G; Verma ND; Robinson CM; Wilcox P; Hodgkinson SJ, 2019, 'Activation of naive CD4+CD25+FOXP3+Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', The Journal of Immunology, 202, pp. 116.16 - 116.16, http://dx.doi.org/10.4049/jimmunol.202.supp.116.16
Bhaskar S; Saab J; Cappelen-Smith C; Killingsworth M; Wu XJ; Cheung A; Manning N; Aouad P; McDougall A; Hodgkinson S; Cordato D, 2019, 'Clot Histopathology in Ischemic Stroke with Infective Endocarditis', Canadian Journal of Neurological Sciences, 46, pp. 331 - 336, http://dx.doi.org/10.1017/cjn.2019.8
Hall BM; Verma ND; Robinson CM; Wang C; Sharland A; Tran G; Wilcox P; Hodgkinson SJ, 2019, 'Recently alloactivated CD4+CD8−CD25+T regulatory cells express CD8alpha and are potent suppressor cells', The Journal of Immunology, 202, pp. 57.20 - 57.20, http://dx.doi.org/10.4049/jimmunol.202.supp.57.20
Hall BM; Rakesh P; Tran G; Hall R; Bedi S; Robinson CM; Sharland A; Wang C; Hodgkinson SJ; Verma ND, 2019, 'Th2 cytokines and specific donor alloantigen activated CD4+CD25+T cells reverse chronic rejection: role of IL-4 and IL-5 in promoting antigen-specific Treg', The Journal of Immunology, 202, pp. 186.11 - 186.11, http://dx.doi.org/10.4049/jimmunol.202.supp.186.11
Bhaskar S; Thomas P; Cheng Q; Clement N; McDougall A; Hodgkinson S; Cordato D, 2019, 'Trends in acute stroke presentations to an emergency department: Implications for specific communities in accessing acute stroke care services', Postgraduate Medical Journal, 95, pp. 258 - 264, http://dx.doi.org/10.1136/postgradmedj-2019-136413
Hodgkinson S; Sharma M, 2019, 'Temporal profile of lymphocytes following treatment with cladribine tablets in patients switching from lymphocyte depleting or sequestering disease modifying drugs (DMDs) (P4.2-034)', Neurology, 92, http://dx.doi.org/10.1212/wnl.92.15_supplement.p4.2-034
Kalincik T; Kubala Havrdova E; Horakova D; Izquierdo G; Prat A; Girard M; Duquette P; Grammond P; Onofrj M; Lugaresi A; Ozakbas S; Kappos L; Kuhle J; Terzi M; Lechner-Scott J; Boz C; Grand'maison F; Prevost J; Sola P; Ferraro D; Granella F; Trojano M; Bergamaschi R; Pucci E; Turkoglu R; McCombe PA; Pesch VV; Van Wijmeersch B; Solaro C; Ramo-Tello C; Slee M; Alroughani R; Yamout B; Shaygannejad V; Spitaleri D; Sánchez-Menoyo JL; Ampapa R; Hodgkinson S; Karabudak R; Butler E; Vucic S; Jokubaitis V; Spelman T; Butzkueven H, 2019, 'Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 458 - 468, http://dx.doi.org/10.1136/jnnp-2018-319831
Nguyen AL; Havrdova EK; Horakova D; Izquierdo G; Kalincik T; van der Walt A; Terzi M; Alroughani R; Duquette P; Girard M; Prat A; Boz C; Sola P; Ferraro D; Lugaresi A; Lechner-Scott J; Barnett M; Grand'Maison F; Grammond P; Ramo-Tello C; Turkoglu R; McCombe P; Pucci E; Trojano M; Granella F; Spitaleri D; Van Pesch V; Soysal A; Oreja-Guevara C; Verheul F; Vucic S; Hodgkinson S; Slee M; Ampapa R; Prevost J; Menoyo JLS; Skibina O; Solaro C; Olascoaga J; Shaw C; Madsen KG; Naidoo K; Hyde R; Butzkueven H; Jokubaitis V, 2019, 'Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study', Multiple Sclerosis and Related Disorders, 28, pp. 235 - 243, http://dx.doi.org/10.1016/j.msard.2019.01.003
Brown JWL; Coles A; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Trojano M; Lugaresi A; Bergamaschi R; Grammond P; Alroughani R; Hupperts R; McCombe P; Van Pesch V; Sola P; Ferraro D; Grand'Maison F; Terzi M; Lechner-Scott J; Flechter S; Slee M; Shaygannejad V; Pucci E; Granella F; Jokubaitis V; Willis M; Rice C; Scolding N; Wilkins A; Pearson OR; Ziemssen T; Hutchinson M; Harding K; Jones J; McGuigan C; Butzkueven H; Kalincik T; Robertson N; Onofrj M; De Luca G; Di Tommaso V; Travaglini D; Pietrolongo E; di Ioia M; Farina D; Mancinelli L; Hodgkinson S; Oreja-Guevara C; Boz C; Prevost J; Olascoaga J; Van Wijmeersch B; Barnett M; Verheul F; Rojas JI; Spitaleri D; Rio ME; Taylor B; Luis Sanchez-Menoyo J; Ramo-Tello C; Solaro C; Csepany T; Iuliano G; Skibina O; Petersen T; Bolanos RF; Sidhom Y; Riadh ; Vucic S; Macdonell R; Sempere AP; Simo M; Kister I; Shuey N; Radek ; Dominguez JA; Pia Amato M; Saladino ML; Kermode A; Butler E; Moore F; Hughes S; McDonnell G; Piroska I; Yamout B; Soysal A; Ozakbas S; Zwanikken C, 2019, 'Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis', JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 321, pp. 175 - 187, http://dx.doi.org/10.1001/jama.2018.20588
Tea F; Lopez JA; Ramanathan S; Merheb V; Lee FXZ; Zou A; Pilli D; Patrick E; van der Walt A; Monif M; Tantsis EM; Yiu EM; Vucic S; Henderson APD; Fok A; Fraser CL; Lechner-Scott J; Reddel SW; Broadley S; Barnett MH; Brown DA; Lunemann JD; Dale RC; Brilot F; Sinclair A; Kermode AG; Kornberg A; Bye A; McGettigan B; Trewin B; Brew B; Taylor B; Bundell C; Miteff C; Troedson C; Pridmore C; Spooner C; Yiannikas C; O'Gorman C; Clark D; Suan D; Jones D; Kilfoyle D; Gill D; Wakefield D; Hofmann D; Mathey E; O'Grady G; Jones HF; Beadnall H; Butzkueven H; Joshi H; Andrews I; Sutton I; MacIntyre J; Sandbach JM; Freeman J; King J; O'Neill JH; Parratt J; Barton J; Garber J; Ahmad K; Riney K; Buzzard K; Kothur K; Cantrill LC; Menezes MP; Paine MA; Marriot M; Ghadiri M; Boggild M; Lawlor M; Badve M; Ryan M; Aaqib M; Shuey N; Jordan N; Urriola N; Lawn N; White O; McCombe P; Patel R; Leventer R; Webster R; Smith R; Gupta S; Mohammad SS; Pillai S; Hawke S; Simon S; Calvert S; Blum S; Malone S; Hodgkinson S; Nguyen TK; Hardy TA; Kalincik T; Ware T; Fung VSC, 2019, 'Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination', Acta Neuropathologica Communications, 7, http://dx.doi.org/10.1186/s40478-019-0786-3
Verma ND; Robinson CM; Carter N; Wilcox P; Tran GT; Wang C; Sharland A; Nomura M; Plain KM; Bishop GA; Hodgkinson SJ; Hall BM, 2019, 'Alloactivation of naïve CD4+ CD8− CD25+T regulatory cells: Expression of CD8α identifies potent suppressor cells that can promote transplant tolerance induction', Frontiers in Immunology, 10, pp. 2397, http://dx.doi.org/10.3389/fimmu.2019.02397
Desai M; Alsahli K; Cheung A; Wenderoth J; Kohli A; Cappelen-Smith C; Cordato D; Tay K; Hodgkinson S; McDougall A; Zagami AS; Manning NW, 2019, 'Abstract 154: Non-Contrast Computed Tomography Based Patient Selection Achieves Similar Outcomes to Advanced Neuroimaging in Late Time Window Endovascular Thrombectomy', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.154
Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van Der Walt A; Butzkueven H; Kalincik T, 2018, 'Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis', JAMA Neurology, 75, pp. 1407 - 1415, http://dx.doi.org/10.1001/jamaneurol.2018.2109
Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Lechner-Scott J; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Solaro C; Grand’Maison F; Hupperts R; Prevost J; Sola P; Ferraro D; Terzi M; Butler E; Slee M; Kermode A; Fabis-Pedrini M; McCombe P; Barnett M; Shaw C; Hodgkinson S; Butzkueven H, 2018, 'Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis', Multiple Sclerosis Journal, 24, pp. 1617 - 1626, http://dx.doi.org/10.1177/1352458517728812
de Stefano N; Achiron A; Barkhof F; Chan A; Derfuss T; Hodgkinson S; Leocani L; Montalban X; Prat A; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Roy S, 2018, 'THE MAGNIFY-MS STUDY: MAVENCLAD (R) TABLETS IN ACTIVE RMS', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 89, http://dx.doi.org/10.1136/jnnp-2018-ABN.81
Kister I; Spelman T; Patti F; Duquette P; Trojano M; Izquierdo G; Lugaresi A; Grammond P; Sola P; Ferraro D; Grand'Maison F; Alroughani R; Terzi M; Boz C; Hupperts R; Lechner-Scott J; Kappos L; Pucci E; Hodgkinson S; Solaro C; Butzkueven H, 2018, 'Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy', Journal of the Neurological Sciences, 391, pp. 72 - 76, http://dx.doi.org/10.1016/j.jns.2018.06.001
Kappos L; Bar-Or A; Cree BAC; Fox RJ; Giovannoni G; Gold R; Vermersch P; Arnold DL; Arnould S; Scherz T; Wolf C; Wallström E; Dahlke F; Achiron A; Achtnichts L; Agan K; Akman-Demir G; Allen AB; Antel JP; Antiguedad AR; Apperson M; Applebee AM; Ayuso GI; Baba M; Bajenaru O; Balasa R; Balci BP; Barnett M; Bass A; Becker VU; Bejinariu M; Bergh FT; Bergmann A; Bernitsas E; Berthele A; Bhan V; Bischof F; Bjork RJ; Blevins G; Boehringer M; Boerner T; Bonek R; Bowen JD; Bowling A; Boyko AN; Boz C; Bracknies V; Braune S; Brescia Morra V; Brochet B; Brola W; Brownstone PK; Brozman M; Brunet D; Buraga I; Burnett M; Buttmann M; Butzkueven H; Cahill J; Calkwood JC; Camu W; Cascione M; Castelnovo G; Centonze D; Cerqueira J; Chan A; Cimprichova A; Cohan S; Comi G; Conway J; Cooper JA; Corboy J; Correale J; Costell B; Cottrell DA; Coyle PK; Craner M; Cui L; Cunha L; Czlonkowska A; da Silva AM; de Sa J; de Seze J; Debouverie M; Debruyne J; Decoo D; Defer G; Derfuss T; Deri NH; Dihenia B; Dioszeghy P; Donath V; Dubois B; Duddy M; Duquette P; Edan G; Efendi H; Elias S; Emrich PJ; Estruch BC, 2018, 'Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study', The Lancet, 391, pp. 1263 - 1273, http://dx.doi.org/10.1016/S0140-6736(18)30475-6
Venkat A; Cappelen-Smith C; Askar S; Thomas PR; Bhaskar S; Tam A; McDougall AJ; Hodgkinson SJ; Cordato DJ, 2018, 'Factors Associated with Stroke Misdiagnosis in the Emergency Department: A Retrospective Case-Control Study', Neuroendocrinology, 51, pp. 123 - 127, http://dx.doi.org/10.1159/000491635
Hardy TA; Young S; Sy JS; Colley AF; Terwindt GM; Ferrari MD; Hayes MW; Hodgkinson S, 2018, 'Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCLS): A role for neuroinflammation?', Journal of Neurology, Neurosurgery and Psychiatry, 89, http://dx.doi.org/10.1136/jnnp-2017-316142
Tran GT; Wilcox PL; Dent LA; Robinson CM; Carter N; Verma ND; Hall BM; Hodgkinson SJ, 2017, 'Interleukin-5 Mediates Parasite-Induced Protection against Experimental Autoimmune Encephalomyelitis: Association with Induction of Antigen-Specific CD4+CD25+ T Regulatory Cells', Frontiers in Immunology, 8, pp. 1453, http://dx.doi.org/10.3389/fimmu.2017.01453
Kalincik T; Manouchehrinia A; Sobisek L; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Girard M; Prat A; Duquette P; Grammond P; Sola P; Hupperts R; Grand'Maison F; Pucci E; Boz C; Alroughani R; Van Pesch V; Lechner-Scott J; Terzi M; Bergamaschi R; Iuliano G; Granella F; Spitaleri D; Shaygannejad V; Oreja-Guevara C; Slee M; Ampapa R; Verheul F; McCombe P; Olascoaga J; Amato MP; Vucic S; Hodgkinson S; Ramo-Tello C; Flechter S; Cristiano E; Rozsa C; Moore F; Sanchez-Menoyo JL; Saladino ML; Barnett M; Hillert J; Butzkueven H, 2017, 'Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response', Brain, 140, pp. 2426 - 2443, http://dx.doi.org/10.1093/brain/awx185
Hall BM; Robinson CM; Plain KM; Verma ND; Tran GT; Nomura M; Carter N; Boyd R; Hodgkinson SJ, 2017, 'Changes in reactivity in vitro of CD4+ CD25+ and CD4+ CD25− T Cell subsets in transplant tolerance', Frontiers in Immunology, 8, pp. 994, http://dx.doi.org/10.3389/fimmu.2017.00994
Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ, 2017, 'Cytokines affecting CD4+ T regulatory cells in transplant tolerance. III. Interleukin-5 (IL-5) promotes survival of alloantigen-specific CD4+ T regulatory cells', Transplant Immunology, 43-44, pp. 33 - 41, http://dx.doi.org/10.1016/j.trim.2017.06.003
Bukhari W; Prain KM; Waters P; Woodhall M; O'Gorman CM; Clarke L; Silvestrini RA; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee WJ; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Killpatrick T; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell R; Mason DF; McCombe PA; Pender MP; Pereira JA; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Wilson RJ; Vincent A; Broadley SA, 2017, 'Incidence and prevalence of NMOSD in Australia and New Zealand', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 632 - 638, http://dx.doi.org/10.1136/jnnp-2016-314839
Gonsalvez DG; Tran G; Fletcher JL; Hughes RA; Hodgkinson S; Wood RJ; Yoo SW; De Silva M; Agnes WW; McLean C; Kennedy P; Kilpatrick TJ; Murray SS; Xiao J, 2017, 'A brain-derived neurotrophic factor-based p75NTR peptide mimetic ameliorates experimental autoimmune neuritis induced axonal pathology and demyelination', eNeuro, 4, http://dx.doi.org/10.1523/ENEURO.0142-17.2017
Nomura M; Hodgkinson SJ; Tran GT; Verma ND; Robinson C; Plain KM; Boyd R; Hall BM, 2017, 'Cytokines affecting CD4+ T regulatory cells in transplant tolerance. II. Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4+ T regulatory cells', Transplant Immunology, 42, pp. 24 - 33, http://dx.doi.org/10.1016/j.trim.2017.05.002
Kalincik T; Brown JWL; Robertson N; Willis M; Scolding N; Rice CM; Wilkins A; Pearson O; Ziemssen T; Hutchinson M; McGuigan C; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Alroughani R; Pucci E; Sola P; Hupperts R; Lechner-Scott J; Terzi M; Van Pesch V; Rozsa C; Grand'Maison F; Boz C; Granella F; Slee M; Spitaleri D; Olascoaga J; Bergamaschi R; Verheul F; Vucic S; McCombe P; Hodgkinson S; Sanchez-Menoyo JL; Ampapa R; Simo M; Csepany T; Ramo C; Cristiano E; Barnett M; Butzkueven H; Coles A, 2017, 'Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study', The Lancet Neurology, 16, pp. 271 - 281, http://dx.doi.org/10.1016/S1474-4422(17)30007-8
Lizak N; Lugaresi A; Alroughani R; Lechner-Scott J; Slee M; Havrdova E; Horakova D; Trojano M; Izquierdo G; Duquette P; Girard M; Prat A; Grammond P; Hupperts R; Grand'Maison F; Sola P; Pucci E; Bergamaschi R; Oreja-Guevara C; Van Pesch V; Ramo C; Spitaleri D; Iuliano G; Boz C; Granella F; Olascoaga J; Verheul F; Rozsa C; Cristiano E; Flechter S; Hodgkinson S; Amato MP; Deri N; Jokubaitis V; Spelman T; Butzkueven H; Kalincik T, 2017, 'Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 88, pp. 196 - 203, http://dx.doi.org/10.1136/jnnp-2016-313976
Tao C; Simpson S; Van Der Mei I; Blizzard L; Havrdova E; Horakova D; Shaygannejad V; Lugaresi A; Izquierdo G; Trojano M; Duquette P; Girard M; Grand'Maison F; Grammond P; Alroughani R; Terzi M; Oreja-Guevara C; Sajedi SA; Iuliano G; Sola P; Lechner-Scott J; Van Pesch V; Pucci E; Bergamaschi R; Barnett M; Ramo C; Singhal B; Spitaleri DLA; Slee M; Verheul F; Fernández Bolaños R; Amato MP; Cristiano E; Granella F; Hodgkinson S; Fiol M; Gray O; McCombe P; Saladino ML; Sánchez Menoyo JL; Shuey N; Vucic S; Shaw C; Deri N; Arruda WO; Butzkueven H; Spelman T; Taylor BV, 2016, 'Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 87, pp. 1343 - 1349, http://dx.doi.org/10.1136/jnnp-2016-314013
Stam AH; Kothari PH; Shaikh A; Gschwendter A; Jen JC; Hodgkinson S; Hardy TA; Hayes M; Kempster PA; Kotschet KE; Bajema IM; Van Duinen SG; Maat-Schieman MLC; De Jong PTVM; De Smet MD; De Wolff-Rouendaal D; Dijkman G; Pelzer N; Kolar GR; Schmidt RE; Lacey JA; Joseph D; Fintak DR; Grand MG; Brunt EM; Liapis H; Hajj-Ali RA; Kruit MC; Van Buchem MA; Dichgans M; Frants RR; Van Den Maagdenberg AMJM; Haan J; Baloh RW; Atkinson JP; Terwindt GM; Ferrari MD, 2016, 'Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations', Brain, 139, pp. 2909 - 2922, http://dx.doi.org/10.1093/brain/aww217
Lorscheider J; Buzzard K; Jokubaitis V; Spelman T; Havrdova E; Horakova D; Trojano M; Izquierdo G; Girard M; Duquette P; Prat A; Lugaresi A; Grand'maison F; Grammond P; Hupperts R; Alroughani R; Sola P; Boz C; Pucci E; Lechner-Scott J; Bergamaschi R; Oreja-Guevara C; Iuliano G; Van Pesch V; Granella F; Ramo-Tello C; Spitaleri D; Petersen T; Slee M; Verheul F; Ampapa R; Amato MP; Mccombe P; Vucic S; Sánchez Menoyo JL; Cristiano E; Barnett MH; Hodgkinson S; Olascoaga J; Saladino ML; Gray O; Shaw C; Moore F; Butzkueven H; Kalincik T, 2016, 'Defining secondary progressive multiple sclerosis', Brain, 139, pp. 2395 - 2405, http://dx.doi.org/10.1093/brain/aww173
Jokubaitis VG; Spelman T; Kalincik T; Lorscheider J; Havrdova E; Horakova D; Duquette P; Girard M; Prat A; Izquierdo G; Grammond P; Van Pesch V; Pucci E; Grand'Maison F; Hupperts R; Granella F; Sola P; Bergamaschi R; Iuliano G; Spitaleri D; Boz C; Hodgkinson S; Olascoaga J; Verheul F; McCombe P; Petersen T; Rozsa C; Lechner-Scott J; Saladino ML; Farina D; Iaffaldano P; Paolicelli D; Butzkueven H; Lugaresi A; Trojano M, 2016, 'Predictors of long-term disability accrual in relapse-onset multiple sclerosis', Annals of Neurology, 80, pp. 89 - 100, http://dx.doi.org/10.1002/ana.24682
Spelman T; Mekhael L; Burke T; Butzkueven H; Hodgkinson S; Havrdova E; Horakova D; Duquette P; Izquierdo G; Grand'Maison F; Grammond P; Barnett M; Lechner-Scott J; Alroughani R; Trojano M; Lugaresi A; Granella F; Pucci E; Vucic S, 2016, 'Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis', European Journal of Neurology, 23, pp. 729 - 736, http://dx.doi.org/10.1111/ene.12929
Hall BM; Tran GT; Robinson CM; Hodgkinson SJ, 2015, 'Induction of antigen specific CD4+CD25+Foxp3+T regulatory cells from naïve natural thymic derived T regulatory cells', International Immunopharmacology, 28, pp. 875 - 886, http://dx.doi.org/10.1016/j.intimp.2015.03.049
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies JM; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2015, 'A new era in the treatment of multiple sclerosis', Medical Journal of Australia, 203, pp. 139 - 141, http://dx.doi.org/10.5694/mja14.01218
Mackay AM; Buckingham R; Schwartz RS; Hodgkinson S; Beran RG; Cordato DJ, 2015, 'The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study', International Journal of MS Care, 17, pp. 141010081652001 - 141010081652001, http://dx.doi.org/10.7224/1537-2073.2014-006
Kister I; Spelman T; Duquette P; Girard M; Lechner-Scott J; Grand'Maison F; Slee M; Hodgkinson S; Lugaresi A; Edite Rio M; Trojano M; Butzkueven H; Herbert J, 2015, '‘Doctor, can I stop my medicine?’ Analysis of disease course after stopping disease-modifying therapy in stable MS patients (P5.192)', Neurology, 84, http://dx.doi.org/10.1212/wnl.84.14_supplement.p5.192
He A; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Lugaresi A; Izquierdo G; Grammond P; Duquette P; Girard M; Pucci E; Iuliano G; Alroughani R; Oreja-Guevara C; Fernandez-Bolaños R; Grand'Maison F; Sola P; Spitaleri D; Granella F; Terzi M; Lechner-Scott J; Van Pesch V; Hupperts R; Sánchez-Menoyo JL; Hodgkinson S; Rozsa C; Verheul F; Butzkueven H; Kalincik T; Giuliani G; Cartechini E; Rio ME; Zwanikken C; Flechter S; Kasa K; Amato MP; Shaygannejad V; Bergamaschi R; Slee M; Boz C; Moore F; Barnett M; Vucic S; McCombe P; Cabrera-Gomez JA; Petersen T; Ramo C; Roullet E; Den Braber-Moerland L; Paolicelli D; Iaffaldano P; Direnzo V; D'Onghia M; Piroska I; Erdelyi T; Iljicsov A; Kovacs K; Sas A; Skibina O; Haartsen J; van Munster E; Fiol M; Correale J; Ysrraelit C; Herbert J; Kister I; Sirbu CA; Shaw C; Vetere S; Petkovska-Boskova T; Singhal B; Bacile EA; Arruda WO; Roger E; Despault P; Marriott M; Van der Walt A; King J; Byron J; Morgan L; Hinson E; De Luca G; Di Tommaso V; Travaglini D; Pietrolongo E; di Ioia M; Farina D; Mancinelli L; Rojas JI; Patrucco L; Williams D; Dark L; Savino A; Chapman J; Cristiano E; Saladino ML; Deri N; Gray O; Hughes S, 2015, 'Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis', JAMA Neurology, 72, pp. 405 - 413, http://dx.doi.org/10.1001/jamaneurol.2014.4147
Arguedas D; Stewart J; Hodgkinson S; Batchelor J, 2015, 'A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson’s Disease', Neurocase, 21, pp. 154 - 161, http://dx.doi.org/10.1080/13554794.2013.878726
Kalincik T; Horakova D; Spelman T; Jokubaitis V; Trojano M; Lugaresi A; Izquierdo G; Rozsa C; Grammond P; Alroughani R; Duquette P; Girard M; Pucci E; Lechner-Scott J; Slee M; Fernandez-Bolanos R; Grand'Maison F; Hupperts R; Verheul F; Hodgkinson S; Oreja-Guevara C; Spitaleri D; Barnett M; Terzi M; Bergamaschi R; McCombe P; Sanchez-Menoyo J; Simo M; Csepany T; Rum G; Boz C; Havrdova E; Butzkueven H, 2015, 'Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis', Annals of Neurology, 77, pp. 425 - 435, http://dx.doi.org/10.1002/ana.24339
Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ, 2015, 'Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab', Journal of Clinical Neuroscience, http://dx.doi.org/10.1016/j.jocn.2014.08.016
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies', Journal of Clinical Neuroscience, 21, pp. 1835 - 1846, http://dx.doi.org/10.1016/j.jocn.2014.01.016
Back to profile page
https://orcid.org/0000-0002-9029-6663